High Body Mass Index Worsens Survival in Patients with Esophageal Squamous Cell Carcinoma after Esophagectomy. 2017

Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.

OBJECTIVE To investigate the prognostic significance of body mass index (BMI) on the survival of patients with esophageal squamous cell carcinoma (ESCC) after esophagectomy. METHODS Between 2005 and 2008, 291 patients with ESCC who met the inclusion criteria were included in the study. The BMI cut-off values were as follows: 18.5-23 kg/m2 for normal weight; 23-27.5 kg/m2 for overweight; and ≥27.5 kg/m2 for those with obesity. Univariate and multivariate analyses were performed to identify prognostic factors for long-term survival. RESULTS Patients were divided into 3 groups: normal weight (n = 138), overweight (n = 103), and obese (n = 50). The median survival time was 56 months. The 5-year overall survival (OS) rates were 40.8, 44.7, and 20.8% for normal weight, overweight, and obese patients respectively (p < 0.05). Multivariate analysis identified BMI as an independent prognostic factor for OS (p < 0.05). For 179 patients without lymph node metastasis, the 5-year OS rates were 46.5, 50.7, and 27.0% for normal weight, overweight, and obese patients respectively (p < 0.05). CONCLUSIONS A BMI ≥27.5 kg/m2 has a distinctly adverse impact on the long-term survival of ESCC patients after esophagectomy. High BMI is a potential predictor of worse prognosis in ESCC patients, particularly in patients without lymph node metastasis.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
February 2015, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
June 2022, Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
February 2020, World journal of gastroenterology,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
February 2013, Japanese journal of clinical oncology,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
January 2021, Nutrition and cancer,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
January 2021, Journal of oncology,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
January 2015, Asia Pacific journal of clinical nutrition,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
March 2015, Journal of thoracic disease,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
January 2009, The Journal of thoracic and cardiovascular surgery,
Xiao-Feng Duan, and Peng Tang, and Xiao-Bin Shang, and Hong-Jing Jiang, and Qiang Zhao, and Zhen-Tao Yu
January 2021, Gastroenterology research and practice,
Copied contents to your clipboard!